Acción UTHR UNITED THERAPEUTICS CORPORATION
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas United Therapeutics Corporation

Acciones

UTHR

US91307C1027

Mercado cerrado - Nasdaq
Otros sitios de cotización
 22:00:00 26/04/2024 		Varia. Cinco días. Varia. 1 de enero.
233,8 USD -0,89 % Gráfico intradía de United Therapeutics Corporation -1,71 % +6,35 %
23/04 Insider de United Therapeutics vendió acciones por valor de 1.704.174 dólares, según un reciente registro de la SEC MT
19/04 Insider de United Therapeutics vendió acciones por valor de 1.704.990 dólares, según un reciente registro de la SEC MT

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
UNITED THERAPEUTICS ANNOUNCES WORLD'S FIRST SUCCESSFUL XENOTHYMOKIDNEY TRANSPLANT
CORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney Transplant
United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024
United Therapeutics Insider Sold Shares Worth $1,704,174, According to a Recent SEC Filing
United Therapeutics Q1 Results Could Fall Short of Market Expectations, Oppenheimer Says
United Therapeutics Insider Sold Shares Worth $1,704,990, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $1,682,819, According to a Recent SEC Filing
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference
United Therapeutics Insider Sold Shares Worth $1,707,775, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $6,831,737, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $4,727,736, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $6,957,709, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $1,394,248, According to a Recent SEC Filing
Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension
Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling
United Therapeutics Corporation Announces Extension of Credit Agreement
United Therapeutics Insider Sold Shares Worth $7,375,339, According to a Recent SEC Filing
United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation
United Therapeutics Corporation announces an Equity Buyback for $1,000 million worth of its shares.
United Therapeutics Insider Sold Shares Worth $7,100,981, According to a Recent SEC Filing
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción UTHR
  4. Noticias United Therapeutics Corporation
  5. Otros idiomas